An observational study in Stable Angina and Unstable Angina, sponsored by Bon-Kwon Koo. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2019-05-02.
Sponsored by Bon-Kwon Koo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 30 studies in Angina, Stable with a site in Korea, Republic of — 1 open to participants now, 5 under way, none of them phase 3. Angina, Stable · Korea, Republic of.
Among the 30 studies in Angina, Stable with a site in Korea, Republic of, this one is one of 3 that started in 2015, is one of 6 observational ones, and was the 28th registered.
344 studies on the registry are indexed under Angina, Stable; 56 are open to participants now.
Browse Angina, Stable studies →1 of the 30 studies in Angina, Stable with a site in Korea, Republic of is open now. Recruiting first, the newest first:
Korea University Guro Hospital · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 38 Angina, Stable studies recruiting now, 32 (84%) set no upper age limit and 2 (5%) stop at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
30 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 3 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 355 is below the median of 508 across 103 observational studies indexed under Angina, Stable.
Median enrollment 114 across the 24 interventional studies, 1,199 across the 6 observational. Of the 17 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 30 have an industry lead sponsor. The 10 most frequent:
Bon-Kwon Koo is the lead sponsor of 5 studies on the registry; 2 are open to participants now.
Bon-Kwon Koo has 1 study filed under Angina, Stable — fewer than ten, so there is no comparison to draw.
1 of the studies in Angina, Stable with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03030495Samsung Medical CenterRegistry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 30 studies in Angina, Stable with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study was performed to investigate the anatomical attributes that determine myocardial territory of diagonal branches and to develop a prediction model for clinically relevant branches using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).
Bifurcation lesion is one of the most challenging lesion subsets in the field of percutaneous coronary intervention (PCI). Despite the recent advances in PCI techniques and stent technology, most randomized studies failed to prove the superiority of systematic 2 stenting strategy compared with provisional side branch intervention strategy.
A certain amount of ischemic burden is required to achieve the benefit of revascularization over medical treatment. Compared with major epicardial vessels, side branches are smaller, more variable in anatomy, supplying less myocardium and less clinically relevant. Therefore, it is important to assess the myocardial mass at risk of side branches to determine the appropriate treatment strategy for bifurcation lesions. However, how to define the clinically relevant side branches which can be associated with the benefit of revascularization in a cardiac catheterization laboratory is not well-known.
The investigators performed this study to investigate the anatomical attributes that determine ischemic burden and myocardial territory of diagonal branches and to develop a prediction model for a clinically relevant diagonal branch using myocardial perfusion imaging (MPI) and coronary CT angiography (CCTA).
Patients with angina pectoris
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
For the MPI arm, patients with severe jailed diagonal branch disease with available MPI in 3 months were selected from the Seoul National University Hospital Cardiac Catheterization and MPI database.
For the CCTA arm, patients from a previous multicenter prospective CCTA registry were retrospectively reviewed for a post-hoc analysis.
Angiographic attributes for diagonal branches
Angiographic attributes for diagonal branches were visually defined as follows : 1. Size was a binary attribute of vessel diameter ≥ 2.5mm or \< 2.5mm. 2. Number was counted as one, two, and 3 or more diagonal branches. 3. Dominancy in patients with 2 diagonal branches (D1/2 dominancy) was a binary attribute for one of two diagonal branches whose diameter was more than two times larger than its smaller counterpart. 4. LCx dominancy was defined as a left-dominant system or a presence of obtuse marginal branch originating within proximal 1/3 of LCx and crossing LAD at right anterior oblique caudal view.
Time frame: through study completion, an average of 1year
Sensitivity of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
Specificity of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
Negative predictive value of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
Positive predictive value of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
Area under the curve of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
Accuracy of prediction model
Prediction model using anatomical attributes to define clinical relevance of diagonal branches will be developed.
Time frame: through study completion, an average of 1year
%Ischemia
Myocardium of perfusion image was divided into 20 segments, and summed rest score (SRS), summed stress score (SSS), and summed difference score (SDS) were scored in each segment according to a 5-grade system (0-4) for the assessment of perfusion status. (1) SSS and SDS of diagonal segments were converted to percent of myocardial ischemia (%ischemia) of diagonal territory by dividing summed scores by 80 and multiplying by 100.
Time frame: through study completion, an average of 1year
%FMM
FMM was calculated using stem-and-crown model as described in the parent study. (2) FMM of each diagonal brach was converted to percent FMM (%FMM) of diagonal branch by dividing each FMM by left ventricular myocardial mass.
Time frame: through study completion, an average of 1year
Ran from Aug 2015 to primary completion in Feb 2017, 18 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bon-Kwon Koo